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Primary spontaneous pneumothorax (PSP), a condition in which air enters the pleural space and causes secondary
lung collapse, is mostly sporadic but also occurs in families. The precise etiology of PSP remains unknown, although
it is associated with emphysemalike changes (bullae) in the lungs of almost all patients. We describe the results of
a genetic study of a large Finnish family with a dominantly inherited tendency to PSP. A genomewide scan suggested
linkage to chromosome 17p11. Screening of the best candidate gene, FLCN, revealed a 4-bp deletion in the first
coding exon, which causes a frameshift that predicts a protein truncation 50 missense amino acids downstream.
All carriers of the deletion had bullous lung lesions. Mutations in FLCN are also responsible for Birt-Hogg-Dube´
(BHD) syndrome (a dominantly inherited disease characterized by benign skin tumors, PSP, and diverse types of
renal cancer) and, rarely, are detected in sporadic renal and colorectal tumors. Unlike other FLCN mutations, the
exon 4 deletion seems to be associated with bullous lung changes only with 100% penetrance. These results suggest
that changes in FLCN may have an important role in the development of PSP and, more importantly, of emphysema,
a chronic pulmonary disease that often leads to formation of bullous lesions and lowered pulmonary function.
Additionally, given the strong association of PSP and BHD, the connection between these conditions needs to be
investigated further, particularly in patients with familial PSP, who may be at a greater risk of developing renal
cancer.
Primary spontaneous pneumothorax (PSP [MIM
173600]) is a condition in which air is present in the
pleural space in the absence of a precipitating event, such
as trauma or lung disease. This results in secondary col-
lapse of the lung, either partially or completely, and some
degree of hypoxia (Sahn and Heffner 2000). PSP is
relatively common, with an incidence between 7.4–18/
100,000 for men and 1.2–6/100,000 for women (Melton
et al. 1979; Bense et al. 1987b) and a dose-dependent,
increased risk among smokers (Bense et al. 1987a). Most
cases are sporadic, typically occurring in tall, thin men
aged 10–30 years (Primrose 1984) and generally while
at rest. Familial PSP is rarer and usually is inherited as
an autosomal dominant condition with reduced pene-
trance (Abolnik et al. 1991; Morrison et al. 1998; Bagchi
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and Nycyk 2002), although X-linked recessive (Abolnik
et al. 1991) and autosomal recessive (Koivisto and Mus-
tonen 2001) inheritance have also been suggested. The
cause of most familial cases is unknown, although PSP
may occur in inherited connective tissue disorders, such
as Marfan (Dwyer and Troncale 1965) and Ehlers-Dan-
los (Dowton et al. 1996) syndromes and may be asso-
ciated with particular human leukocyte antigens (Sharpe
et al. 1980; Yamada et al. 2003) and alpha 1–antitrypsin
deficiency (Daniel and Teba 2000).
Although PSP is said to occur without underlying lung
disease, almost all patients have subpleural blebs or bul-
lae in their lungs, detectable by computed tomography,
thoracoscopy, or thoracotomy (Schramel et al. 1997).
Bullae, or localized emphysemalike changes (ELCs), are
thin-walled air spaces 11 cm in diameter, distal to terminal
bronchioles, and associated with lung-tissue destruction.
The development of ELCs is associated with degradation
of the elastic fibers of the lung (Fukuda et al. 1994) and
is thought to involve complex interactions between in-
flammatory processes, protease-antiprotease and oxidant-
antioxidant imbalances, matrix remodeling, and me-
chanical forces (Suki et al. 2003).
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Figure 1 Simplified pedigree of the Finnish family with PSP. HRCT (indicated by an asterisk [*]) was performed for all living family
members except individual 25. Affected members (blackened symbols) have 1 bullae on their lungs, detected by HRCT or during surgery
(individual 25). Arrows indicate those who had experienced a PSP episode, and numbers indicate those from whom DNA samples were obtained.
The presence of bullae could not be confirmed for two individuals who died prior to the study; hence, they were classified as unaffected, even
though both had experienced PSP.
Figure 2 HRCT scan of the index patient, who experienced
recurrent episodes of PSP. Numerous bullae are visible, seen as clear,
black areas. The two largest bullae are indicated with arrows.
We recently identified a large Finnish pedigree with a
tendency to PSP, which appears to be dominantly inher-
ited (fig. 1). Here, we report the results of a genomewide
scan and the identification of a deletion in the folliculin
gene (FLCN [MIM 607273; GenBank accession number
NM_144997]), also responsible for Birt-Hogg-Dube´ syn-
drome (BHD [MIM 135150]). The family was identified
through the index patient (individual 15), who had been
referred to the Department of Clinical Genetics at the
Helsinki University Central Hospital to be evaluated for
a possible connective-tissue disorder. Clinical examina-
tions (conducted independently by K.A. and M.S.) re-
vealed no clinical signs or symptoms of either Marfan
syndrome or Ehlers-Danlos syndrome. Alpha 1–antitryp-
sin deficiency was also excluded. This woman had ex-
perienced PSP twice, and her son (individual 25) once.
Both individuals had numerous bullae on their lungs (fig.
2). Subsequently, the lungs of 28 additional family mem-
bers were examined with high-resolution computed to-
mography (HRCT). Twelve of these family members had
between 1 and 130 bullae, 1–6 cm in diameter, randomly
situated in the lungs. All individuals with bullae (14 in
total) were classified as “affected.” One female (individ-
ual 7), whose son (individual 23) had bullae and had
experienced a PSP episode, had a normal HRCT. PSP
history was determined by interviewing family members
and was confirmed from hospital records, when avail-
able. In total, eight members (including two who had
died prior to the study) had each had between one and
four PSP episodes. Informed consent was obtained from
all participating family members, and the study was ap-
proved by the institutional ethics committee.
Genomic DNA was extracted from blood samples of
25 family members, 13 affected and 12 unaffected. The
genome-scan genotyping and scoring was performed by
the Finnish Genome Center, University of Helsinki, by
use of the Linkage Mapping Set MD10 (Applied Biosys-
tems), with an average intermarker distance of 10 cM.
Genotypes were obtained for 371 markers. Two-point
LOD scores were calculated with the MLINK program
of the FASTLINK package (Cottingham et al. 1993), and
multipoint and two-point nonparametric linkage (NPL)
scores were calculated with GENEHUNTER 2.0 (Krug-
lyak et al. 1996). For all analyses, inheritance was as-
sumed to be autosomal dominant with reduced pene-
trance (85%), with a disease allele frequency of 0.001.
Allele frequencies for each marker were the same as for
the Finnish population (Finnish Genome Center).
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Figure 3 A 4-bp deletion in exon 4 of the FLCN gene. A, Exon
4 sequence. The deletion is underlined. B, Unaffected control sequence.
C, Affected sequence, showing the wild-type and c.733delTCGG alleles.
Evidence of linkage was observed on chromosome
17p11, with single-point linkage peaks at markers
D17S1852 ( ; ) and D17S798NPL p 2.31 P p .006
( at recombination fraction ).LOD p 3.43 [v] p 0.001
Haplotype analysis defined the region shared by all af-
fected family members to ∼34 cM between these two
markers. The marker closest to the multipoint linkage
peak ( ; ) was D17S1857. Lo-NPL p 13.45 P p .0009
cated between D17S1857 and D17S798 is the FLCN
gene, responsible for BHD. This gene was a very good
positional candidate because of the 50-fold increased
risk of PSP in patients with BHD (Zbar et al. 2002).
Primers for the amplification and sequencing of the 14
exons were as detailed by Nickerson et al. (2002).
We found a 4-bp deletion (c.733delTCGG) in exon 4,
the first coding exon, of FLCN (fig. 3). (Note that this
numbering is in reference to GenBank mRNA sequence
NM_144997.) Previous mutations have been annotated
in reference to GenBank sequence AF517523, which con-
tains 43 fewer bases of 5′ UTR sequence (the equivalent
base in the AF517523 mRNA sequence is nt 690). The
4-bp deletion would cause a frameshift and would result
in a TGA termination codon 50 missense amino acids
downstream. All family members with bullous lung le-
sions were heterozygous for this deletion, with the ex-
ception of one male (individual 23), who had experi-
enced one PSP episode. Although his mother (individual
7) was a suspected PSP carrier, her normal HRCT result
indicated that she did not have the deletion. The apical
location of his bullae (bullae typically occur near the
lung apex in sporadic cases but are situated randomly
in familial ones) strongly suggests that individual 23 ex-
perienced PSP as a sporadic event and not through in-
herited susceptibility.
The deletion was not present in unaffected family mem-
bers or in control samples comprising 100 healthy Finn-
ish individuals and a subgroup of 50 individuals born in
the Savo region, an area of early settlement for the Finn-
ish population and the birthplace of the grandparents
of the index subject (controls were screened by dena-
turing high-performance liquid chromotography with a
3500HT WAVE [Transgenomic]). The absence of the
deletion in unaffected family members indicates that the
penetrance of this mutation in this family is extremely
high—apparently 100%—when the presence or absence
of bullae is considered as the affection status. Generally,
affection status in families with PSP is determined by
pneumothorax episodes; hence, penetrance has been sug-
gested to be fairly low, 50% for males and 34% for
females (Abolnik et al. 1991). Indeed, had we considered
only PSP episodes, penetrance estimates for this family
would have been similarly low, particularly for females
(two of eight cases). Our results highlight the particular
importance of consideration of bullous lung changes in
familial PSP.
To date, most of the reported mutations in FLCN cause
BHD syndrome (Birt et al. 1977), a dominantly inherited
condition characterized by multiple, benign tumors of
the hair follicle (fibrofolliculomas) that typically appear
as pale or skin-colored papules over the face, neck, and
upper trunk at age ∼20–30 years. In addition, 70% of
patients with BHD have pulmonary cysts, 25% expe-
rience PSP, and 15%–30% develop diverse types of renal
cancer (Choyke et al. 2003). Other manifestations, par-
ticularly colorectal tumors (Khoo et al. 2002), have been
reported but are not considered to be part of the BHD
phenotype (Zbar et al. 2002; Vincent et al. 2003). More
rarely, somatic mutations, loss of heterozygosity, and
methylation of the promotor have been detected in di-
verse types of sporadic renal and colorectal tumors (Khoo
et al. 2002, 2003; da Silva et al. 2003; Shin et al. 2003;
Nagy et al. 2004), consistent with the Knudson two-hit
model (Knudson 1971), which highlights a potential role
for FLCN as a tumor-suppressor gene.
The Finnish family under investigation appears to ex-
perience only PSP—there are no obvious indications of
fibrofolliculomas (or other benign skin tumors) or renal
cancer in any member. There are a number of possible
explanations for this. The absence of BHD symptoms
may be due to the location of the deletion, which occurs
in the first coding exon. Whereas almost all mutations
in FLCN reported to date are truncating, most BHD-
and cancer-associated mutations, with the exception of
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one somatic exon 4 missense mutation in one colorectal
carcinoma (Kahnoski et al. 2003), occur downstream in
the gene. Of familial and sporadic BHD mutations,
∼50% are due to indels in a mutation hotspot in a C8
tract in exon 11. Alternatively, given that less than half
of all patients with BHD develop renal cancer and that
FLCN mutations are found in only a small number of
sporadic renal and colorectal tumors, the cancer phe-
notype may be determined by other modifier genes that
are absent from this particular family or from the Finnish
population.
It is also possible that the deletion does, in fact, cause
BHD in this family and that either the BHD phenotype
is very mild and atypical, in that PSP is the predominant
manifestation, or the onset of the characteristic skin mani-
festation is delayed. Fibrofolliculomas typically develop
in patients with BHD by age 40 years. Prior to this age,
patients are more likely to experience PSP than are older
patients, whereas those aged 140 years, particularly af-
fected men, are more likely to develop renal cancers (Zbar
et al. 2002) than are younger patients.
The affected members of the family with PSP currently
have an age range of 21–83 years (average age 49 years),
and all but three affected members are aged 44 years.
Since this family was initially ascertained as suffering from
PSP, the members were not screened for specific BHD
manifestations. However, prior to the discovery of the
deletion, several family members were independently ex-
amined by experienced clinical geneticists (K.A. and M.S.)
for the possibility of an unknown syndrome. Skin was
examined particularly closely for signs of Ehlers-Danlos
syndrome (for which the genotype is skin that is variably
thin, hyperextensible, and prone to bruising). Because
of the close association of PSP and BHD, Zbar et al.
(2002) suggested that the BHD gene, then unidentified,
might be responsible for some cases of familial PSP and
that PSP could be used as a diagnostic criterion for BHD
in members of families with BHD. Our results highlight
the need to also consider the possibility of BHD in fami-
lies with PSP, particularly from a clinical perspective,
since these patients may be at greater risk of developing
renal cancer. We are currently organizing genetic coun-
seling and appropriate examinations, including abdomi-
nal scans, for consenting family members.
At this point, we can only speculate as to the potential
role of FLCN in PSP. The function of the FLCN protein
is currently unknown, and it has no known human homo-
logs, although the protein is highly conserved across spe-
cies (Nickerson et al. 2002). In two animal models, Ger-
man Shepherd dogs (Lingaas et al. 2003) and the Nihon
rat (Okimoto et al. 2004), heterozygous mutations cause
renal cancer with apparently complete penetrance, and
there is evidence of a homozygous lethal effect. In hu-
mans, FLCN mRNA is selectively expressed in specific
cell types in a number of tissues, including skin, lung,
kidney, pancreas, breast, prostate, and cerebellum, which
suggests roles in secretion or endocytosis/phagocytosis,
in addition to tumor suppression (Warren et al. 2004).
A role in secretion is supported by the findings (1) of
Nickerson et al. (2002), which suggest a defect in the
interaction between epithelial and mesenchymal cells in
fibrofolliculomas of patients with BHD, and (2) of Shin
et al. (2003), which suggest that cellular proliferation in
colorectal cancer is affected by alteration of the extra-
cellular matrix composition.
The precise pathogenesis of PSP is also unclear. Bullae
are associated with PSP but may be more indicative than
causative of underlying changes to the lungs. Whether
bullae are the site of rupture—and whether thay have
predictive value for the occurrence and recurrence of
PSP—are the subjects of considerable debate (see Schra-
mel and Zanen [2001]). The development of both bullae
and PSP is, however, associated with degradation of elas-
tic fibers in the lung. In emphysema, this degradation is
initiated by a protease-antiprotease and an oxidant-anti-
oxidant imbalance that result from an influx of inflam-
matory cells, particularly macrophages (Barnes 2000).
The role of inflammation in the initiation of ELCs is sup-
ported by evidence from smokers, who have increased
numbers of bronchial macrophages in addition to a 9-
fold increased risk among women and a 22-fold in-
creased risk among men of developing pneumothorax
(Bense et al. 1987a).
Within the lung, FLCN mRNA is expressed most
strongly in the stromal cells (macrophages and fibro-
blasts) of the connective tissue and in macrophages within
the alveolar space and is expressed moderately in type
I pneumocytes, the epithelial cells lining alveoli (Warren
et al. 2004). This expression pattern suggests that the
effect of the mutation in lungs may be mediated, par-
ticularly through macrophages and possibly through fi-
broblasts. Both cell types variously secrete a complex
mix of factors—including cytokines, chemokines, and
proteases—and an imbalance may either induce an in-
flammatory response even in the absence of an obvious
trigger (such as cigarette smoke) or alter matrix degra-
dation and remodeling.
In this Finnish family, a 4-bp deletion in FLCN causes
inherited PSP. However, determination of the general im-
portance of FLCN in the development of PSP requires
further screening of both familial and sporadic patients
for mutations in this gene. This, in turn, may help to
elucidate the function of the FLCN protein in the lung,
in association with PSP and, even more importantly, with
generalized emphysema, and perhaps may shed further
light on its role in tumorogenesis.
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